Clinical Oncology Next Generation Sequencing Market Analysis & Forecast by Key Players, Share, Trend, Segmentation

Clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate

Global Clinical Oncology Next Generation Sequencing Market report is an analytical estimation of the key challenges in terms of sales, export/import, or revenue that an organization may have to face in the coming years.  Not to mention, the data is collected only from the dependable sources such as journals, newspapers, company websites and annual reports of the companies on which Healthcare industry can rely confidently. This market report also comprises of strategic profiling of key players in the market, systematic analysis of their core competencies, and draws a competitive landscape for the market. The worldwide Global Clinical Oncology Next Generation Sequencing Market research report makes use of an excellent research methodology which focuses on market share analysis and key trend analysis.

Market Analysis and Size

According to the American Cancer Society, 1.7 million additional cancer cases and 0.6 million cancer deaths occurred in the United States in 2019. Lung, prostate, bladder, and female breast cancer are the four most common cancers worldwide, accounting for 43% of all new cancer cases. As a result, demand for clinical oncology next-generation sequencing is predicted to rise as cancer incidence rates rise globally. Clinical oncology next-generation sequencing companies are increasingly investing in workflow automation to improve accuracy and lower sample-to-sample variability.

Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029.

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

This clinical oncology next generation sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical oncology next generation sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Download PDF Sample: - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-oncology-next-generation-sequencing-market

Global Clinical Oncology Next Generation Sequencing Market Scope

The clinical oncology next generation sequencing market is segmented on the basis of technology, workflow, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing and Resequencing Centrifuges

Workflow

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

 

Application

  • Screening
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Other Diagnostics

End-user

  • Hospitals
  • Clinics
  • Laboratories

View Detailed Global Clinical Oncology Next Generation Sequencing Market @ https://www.databridgemarketresearch.com/reports/global-clinical-oncology-next-generation-sequencing-market

Competitive Landscape and Clinical Oncology Next Generation Sequencing Market Share Analysis

The clinical oncology next generation sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clinical oncology next generation sequencing market.

Some of the major players operating in the clinical oncology next generation sequencing market are:

  • Illumina, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies Inc. (U.S.)
  • Myriad Genetics Inc. (U.S.)
  • BGI (China)
  • Perkin Elmer Inc. (U.S.)
  • Foundation Medicine Inc. (U.S.)
  • PacBio (U.S.)
  • Oxford Nanopore Technologies plc. (U.K.)
  • Paradigm Diagnostics Inc. (U.S.)
  • Caris Life Sciences (Japan)
  • Partek, Incorporated (U.S.)
  • Eurofins Scientific (Luxembourg)
  • Qiagen (Germany)

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com


dbmrmarket

75 Blog posts

Comments